Transcriptional suppression of the adrenal cortical peripheral-type benzodiazepine receptor gene and inhibition of steroid synthesis by ginkgolide B

Biochemical Pharmacology

Volumn 65, Issue 5, 2003, Pages 717-729

  Amri, Hakima ^a   Drieu, Katy ^b   Papadopoulos, Vassilios ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b Institut Henri Beaufour   (France)

Author keywords

Adrenal cortex; Gene transcription; Ginkgolide B; PBR gene promoter; Peripheral type benzodiazepine receptor (PBR); Steroid biosynthesis

Indexed keywords

BENZODIAZEPINE RECEPTOR; BINDING PROTEIN; CHOLESTEROL BINDING PROTEIN; CORTICOSTEROID; CYTOCHROME P450; DNA FRAGMENT; GINKGO BILOBA EXTRACT; GINKGOLIDE B; MESSENGER RNA; STEROID; STEROID 17ALPHA MONOOXYGENASE; UNCLASSIFIED DRUG; VITAMIN;

ADRENAL CORTEX; ADRENAL CORTEX CELL; ADRENAL GLAND; ADULT; ANIMAL TISSUE; BRAIN; CELL LINE; CONFERENCE PAPER; CONTROLLED STUDY; DNA SEQUENCE; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; GINKGO BILOBA; HUMAN; HUMAN TISSUE; KIDNEY; LIGAND BINDING; LIVER; MALE; MITOCHONDRION; NONHUMAN; PBR GENE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DNA INTERACTION; RAT; RECEPTOR GENE; SCHOOL CHILD; STEROIDOGENESIS; SV40 GENE; TESTIS; TRANSCRIPTION INITIATION SITE; VIRUS GENE;

EID: 0037333821     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01603-9     Document Type: Conference Paper

References (39)

1. Papadopoulos V. Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: biological role in steroidogenic cell function. Endocr. Rev. 14:1993;222-240.
2. McEnery M.W., Snowman A.M., Trifiletti R.R., Snyder S.H. Isolation of the mitochondrial benzodiazepine receptor: association with the voltage-dependent anion channel and the adenine nucleotide carrier. Proc. Natl. Acad. Sci. U.S.A. 89:1992;3170-3174.
3. Garnier M., Dimchev A.B., Boujrad N., Price J.M., Musto N.A., Papadopoulos V. In vitro reconstitution of a functional peripheral-type benzodiazepine receptor from mouse Leydig tumor cells. Mol. Pharmacol. 45:1994;201-211.
4. Anholt R.R.H., Pedersen P.L., DeSouza E.B., Snyder S.H. The peripheral-type benzodiazepine receptor: localization to the mitochondrial outer membrane. J. Biol. Chem. 261:1996;576-583.
5. Papadopoulos V., Mukhin A.G., Costa E., Krueger K.E. The peripheral-type benzodiazepine receptor is functionally linked to Leydig cell steroidogenesis. J. Biol. Chem. 265:1990;3772-3779.
6. Krueger K.E., Papadopoulos V. Peripheral-type benzodiazepine receptors mediate translocation of cholesterol from outer to inner mitochondrial membranes in adrenocortical cells. J. Biol. Chem. 265:1990;15015-15022.
7. Papadopoulos V., Nowzari F.B., Krueger K.E. Hormone-stimulated steroidogenesis is coupled to mitochondrial benzodiazepine receptors. J. Biol. Chem. 266:1991;3682-3687.
8. Papadopoulos V., Amri H., Li H., Boujrad N., Vidic B., Garnier M. Targeted disruption of the peripheral-type benzodiazepine receptor gene inhibits steroidogenesis in the R2C Leydig tumor cell line. J. Biol. Chem. 272:1997;32129-32135.
9. Li H., Yao Z.-X., Degenhardt B., Teper G., Papadopoulos V. Cholesterol binding at the cholesterol recognition/interaction amino acid consensus (CRAC) of the peripheral-type benzodiazepine receptor and inhibition of steroidogenesis by an HIV TAT-CRAC peptide. Proc. Natl. Acad. Sci. U.S.A. 98:2001;1267-1272.
10. Lacapère J.-J., Delavoie F., Li H., Péranzi G., Maccario J., Papadopoulos V., Vidic B. Structural and function study of reconstituted peripheral benzodiazepine receptor. Biochem. Biophys. Res. Commun. 284:2001;536-541.
11. Li H., Papadopoulos V. Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology. 139:1998;4991-4997.
12. DeFeudis FV. Ginkgo biloba extract (EGb 761): from chemistry to the clinic. Wiebaden: Ullestein Medical; 1998.
13. Porsolt R.D., Martin P., Lenègre A., Fromage S., Drieu K. Effects of an extract of Ginkgo biloba (EGb 761) on "learned helplessness" and other models of stress in rodents. Pharmacol. Biochem. Behav. 36:1990;963-971.
14. McEwen B.S. Corticosteroids and hippocampal plasticity. Ann. N.Y. Acad. Sci. 746:1994;134-144.
15. Sapolsky R.M. Why stress is bad for your brain. Science. 273:1996;749-750.
16. Amri H., Ogwuegbu S.O., Boujrad N., Drieu K., Papadopoulos V. In vivo regulation of peripheral-type benzodiazepine receptor and glucocorticoid synthesis by the Ginkgo biloba extract EGb 761 and isolated ginkgolides. Endocrinology. 137:1996;5707-5718.
17. Amri H., Drieu K., Papadopoulos V. Ex vivo regulation of adrenal cortical cell steroid and protein synthesis, in response to adrenocorticotropic hormone stimulation, by the Ginkgo biloba extract EGb 761 and isolated ginkgolide B. Endocrinology. 138:1997;5415-5426.
18. Casalotti S.O., Pelaia G., Yakovlev A.G., Csikós T., Grayson D.R., Krueger K.E. Structure of the rat gene encoding the mitochondrial benzodiazepine receptor. Gene. 121:1992;377-382.
19. Lin D., Chang Y.J., Strauss J.F. III, Miller W.L. The human peripheral benzodiazepine receptor gene: cloning and characterization of alternative splicing in normal tissues and in a patient with congenital lipoid adrenal hyperplasia. Genomics. 18:1993;643-650.
20. Oberto A., Longone P., Krueger K. Identification of three transcriptional regulatory elements in the rat mitochondrial benzodiazepine receptor-encoding gene. Gene. 167:1995;255-260.
21. Mukhin A.G., Papadopoulos V., Costa E., Krueger K.E. Mitochondrial benzodiazepine receptors regulate steroid biosynthesis. Proc. Natl. Acad. Sci. U.S.A. 86:1989;9813-9816.
22. Munson P.J., Rodbard D. LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107:1980;220-239.
23. Bacchetti S., Graham F.L. Transfer of the gene for thymidine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNA. Proc. Natl. Acad. Sci. U.S.A. 74:1977;1590-1594.
24. C17-20-lyase gene (Cyp17): transcriptional regulation of the gene by cyclic adenosine 3′,5′-monophosphate in MA-10 Leydig cells. Mol. Endocrinol. 6:1992;927-934.
25. Andrews N.C., Faller D.V. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:1991;2499.
26. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
27. Blough E., Dineen B., Esser K. Extraction of nuclear proteins from striated muscle tissue. Biotechniques. 26:1999;202-206.
28. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
29. Chrousos G.P., Gold P.W. The concepts of stress and stress system disorders. JAMA. 267:1992;1244-1252.
30. Lupien S.J., de Leon M., de Santi S., Convit A., Tarshish C., Nair N.P., Thakur M., McEwen B.S., Hauger R.L., Meaney M.J. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat. Neurosci. 1:1998;69-73.
31. Le Bars PL, Katz MM, Berman N, Itil TM, Freedman AM, Schatzberg AF for the North American EGb Study Group. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. JAMA 1997;278:1327-32.
32. Christen Y. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 71:2000;621S-629S.
33. Rapin J.R., Lamproglou I., Drieu K., DeFeudis F.V. Demonstration of the "anti-stress" activity of an extract of Ginkgo biloba (EGb 761) using a discrimination learning task. Gen. Pharmacol. 25:1994;1009-1016.
34. Tsai M.J., O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63:1994;451-486.
35. Corton J.C., Anderson S.P., Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu. Rev. Pharmacol. Toxicol. 40:2000;491-518.
36. Biber A., Koch E. Bioavailability of ginkgolides and bilobalide from extracts of Ginkgo biloba using GC/MS. Planta Med. 65:1999;192-193.
37. Kanowski S., Herrmann W.M., Stephan K., Wierich W., Hörr R. Proof of efficacy of Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry. 29:1996;47-56.
38. Hofferberth B. The efficacy of EGb 761 in patients with senile dementia of the Alzheimer type, a double-blind, placebo controlled study on different levels of investigation. Hum. Psychopharmacol. 9:1994;215-222.
39. Oken B.S., Storzbach D.M., Kaye J.A. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch. Neurol. 55:1998;1409-1415.